Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2
- PMID: 19706677
- PMCID: PMC2736867
- DOI: 10.1242/jcs.053124
Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2
Abstract
Vascular endothelial growth factor (VEGF)-induced receptor phosphorylation is the crucial step for initiating downstream signaling pathways that lead to angiogenesis or related pathophysiological outcomes. Our previous studies have shown that the neurotransmitter dopamine could inhibit VEGF-induced phosphorylation of VEGF receptor 2 (VEGFR-2), endothelial cell proliferation, migration, microvascular permeability, and thus, angiogenesis. In this study, we address the mechanism by which VEGFR-2 phosphorylation is regulated by dopamine. Here, we demonstrate that D2 dopamine receptor (D2DR) colocalizes with VEGFR-2 at the cell surface. Dopamine pretreatment increases the translocation and colocalization of Src-homology-2-domain-containing protein tyrosine phosphatase (SHP-2) with D2DR at the cell surface. Dopamine administration leads to increased VEGF-induced phosphorylation of SHP-2 and this increased phosphorylation parallels the increased phosphatase activity of SHP-2. Active SHP-2 then dephosphorylates VEGFR-2 at Y951, Y996 and Y1059, but not Y1175. We also observe that SHP-2 knockdown impairs the dopamine-regulated inhibition of VEGF-induced phosphorylation of VEGFR-2 and, subsequently, Src phosphorylation and migration. Our data establish a novel role for SHP-2 phosphatase in the dopamine-mediated regulation of VEGFR-2 phosphorylation.
Figures
Similar articles
-
Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF.J Biol Chem. 2006 Nov 10;281(45):34009-20. doi: 10.1074/jbc.M603928200. Epub 2006 Sep 10. J Biol Chem. 2006. PMID: 16966330
-
Selective inhibition of vascular endothelial growth factor receptor-2 (VEGFR-2) identifies a central role for VEGFR-2 in human aortic endothelial cell responses to VEGF.J Recept Signal Transduct Res. 2003;23(2-3):239-54. doi: 10.1081/rrs-120025567. J Recept Signal Transduct Res. 2003. PMID: 14626450
-
Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells.Angiogenesis. 2011 Mar;14(1):29-45. doi: 10.1007/s10456-010-9193-x. Angiogenesis. 2011. Retraction in: Angiogenesis. 2011 Sep;14(3):409-10. doi: 10.1007/s10456-011-9225-1. PMID: 21061058 Retracted.
-
Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis.J Atheroscler Thromb. 2006 Jun;13(3):130-5. doi: 10.5551/jat.13.130. J Atheroscler Thromb. 2006. PMID: 16835467 Review.
-
[Research progress of protein tyrosine phosphatase SHP-2].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012 Sep;41(5):581-5. doi: 10.3785/j.issn.1008-9292.2012.05.019. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 23086654 Review. Chinese.
Cited by
-
Effect of Dopamine as a Vascular Endothelial Growth Factor Antagonist on the Development of Acute Lung Injury in Sepsis Patients.Cureus. 2024 Jul 8;16(7):e64102. doi: 10.7759/cureus.64102. eCollection 2024 Jul. Cureus. 2024. PMID: 39114208 Free PMC article.
-
DRD2 activation inhibits choroidal neovascularization in patients with Parkinson's disease and age-related macular degeneration.J Clin Invest. 2024 Jul 16;134(17):e174199. doi: 10.1172/JCI174199. J Clin Invest. 2024. PMID: 39012703 Free PMC article.
-
Preparation and characterization of vaginal suppository of semisynthetic derivatives of ergot alkaloids cabergoline.Saudi Pharm J. 2023 Dec;31(12):101849. doi: 10.1016/j.jsps.2023.101849. Epub 2023 Nov 4. Saudi Pharm J. 2023. PMID: 38028218 Free PMC article.
-
Dopamine signaling from ganglion cells directs layer-specific angiogenesis in the retina.Curr Biol. 2023 Sep 25;33(18):3821-3834.e5. doi: 10.1016/j.cub.2023.07.040. Epub 2023 Aug 11. Curr Biol. 2023. PMID: 37572663 Free PMC article.
-
Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis.Int J Mol Sci. 2023 Jun 15;24(12):10199. doi: 10.3390/ijms241210199. Int J Mol Sci. 2023. PMID: 37373348 Free PMC article. Review.
References
-
- Basu, S. and Dasgupta, P. S. (2000). Role of dopamine in malignant tumor growth. Endocrine 12, 237-241. - PubMed
-
- Basu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Bliss, V. S., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F. and Mukhopadhyay, D. (2001). The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat. Med. 7, 569-574. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous